We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Resumes Domestic Inspections Using New Risk Assessment System
FDA Resumes Domestic Inspections Using New Risk Assessment System
FDA Commissioner Stephen Hahn said that the agency will resume domestic inspections this month using a new risk assessment system developed in response to the pandemic.
To View This Article:
Login
Subscribe To International Devices & Diagnostics Monitor